During the past decade, Norton Brownsboro Hospital and Medical Campus conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 10 clinical trials were completed, i.e. on average, 43.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 10 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Norton Brownsboro Hospital and Medical Campus" #1 sponsor was "National Cancer Institute (NCI)" with 6 trials, followed by "SWOG Cancer Research Network" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "NRG Oncology" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Norton Brownsboro Hospital and Medical Campus" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Brain Science Foundation" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Norton Brownsboro Hospital and Medical Campus" are "Recurrent Squamous Cell Lung Carcinoma" (5 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials), "Oropharyngeal Squamous Cell Carcinoma" (2 trials), "Ovarian Seromucinous Carcinoma" (2 trials) and "Recurrent Fallopian Tube Carcinoma" (2 trials). Many other conditions were trialed in "Norton Brownsboro Hospital and Medical Campus" in a lesser frequency.

Most popular intervention types in "Norton Brownsboro Hospital and Medical Campus" are "Drug" (18 trials), "Other" (16 trials), "Biological" (8 trials), "Radiation" (6 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (8 trials), "Quality-of-Life Assessment" (8 trials), "Questionnaire Administration" (5 trials), "Carboplatin" (4 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Norton Brownsboro Hospital and Medical Campus" are 21 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Norton Brownsboro Hospital and Medical Campus". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Norton Brownsboro Hospital and Medical Campus, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Norton Brownsboro Hospital and Medical Campus, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Norton Brownsboro Hospital and Medical Campus has several departments that took part in Clinical trials: "Norton Suburban Hospital" - 17 trials